NCT05328401 To Evaluate the Therapeutic Effect of Laser Acupuncture in Patients With Acute or Subacute Post Stroke Shoulder Pain
| NCT ID | NCT05328401 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Post Stroke Shoulder Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2022-04-16 |
| Primary Completion | 2028-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2022-04-16 with a primary completion date of 2028-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigators propose a research design protocol to evaluate the efficacy of laser acupuncture in improving shoulder pain and improving shoulder function recovery after stroke.
Eligibility Criteria
Inclusion Criteria: * Beyond the age of 20. * Normal consciousness before and after stroke who can reply and fill in the questionnaire. * Subacute (subacute phase: 7 days to 6 months after stroke) and Chronic (chronic phase: more than 6 months after stroke) with shoulder pain after stroke and in post- stroke recovery period. * Stop taking painkillers for more than 1 day, * Without received intramuscular drugs (steroids, botulinum toxin, glucose, etc.) injections in the shoulder joint or around the shoulder for more than 2 weeks * Those willing to sign the written subject consent form. Exclusion Criteria: * Participants with shoulder pain symptoms before the stroke * Acute shoulder trauma on the affected side of shoulder pain in the past. * Surgery on the affected side of shoulder pain in the past. * Those who cannot complete the scale assessment due to aphasia, post-stroke depression, and obvious cognitive impairment. * Women who are pregnant or planning to become pregnant. * Those who have a history of epilepsy and are receiving anti-epileptic drug treatment. * Who are receiving any herbal or folk remedies related to shoulder pain. * Any other conditions deemed unsuitable in the assessment of the responsible physician. * Those who have not signed the written subject consent form.
Contact & Investigator
Yu Wei Chang
STUDY DIRECTOR
Chang Gung Medical Foundation
Frequently Asked Questions
Who can join the NCT05328401 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Post Stroke Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05328401 currently recruiting?
Yes, NCT05328401 is actively recruiting participants. Contact the research team at yahwehmax@cgmh.org.tw for enrollment information.
Where is the NCT05328401 trial being conducted?
This trial is being conducted at Keelung, Taiwan.
Who is sponsoring the NCT05328401 clinical trial?
NCT05328401 is sponsored by Chang Gung Memorial Hospital. The principal investigator is Yu Wei Chang at Chang Gung Medical Foundation. The trial plans to enroll 58 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.